Birrenbach, T.
Bühlmann, F.
Exadaktylos, A. K.
Hautz, W. E.
Müller, M.
Sauter, T. C.
Article History
Received: 10 February 2022
Accepted: 7 June 2022
First Online: 21 June 2022
Declarations
:
: This study was classified as a quality evaluation study by the local institutional review board (Kantonale Ethikkommission Bern (KEK), BASEC-Number Req-2020–01266). Informed consent for study participation was obtained from each patient. All methods were carried out in accordance with relevant guidelines and regulations.
: Informed consent for publication of study results was obtained from each patient. No individual details are revealed in the publication.
: WEH has received research funding from the European Union, the Swiss National Science foundation, Zoll foundation, Dräger Medical Germany, Mundipharma Research UK, MDI International Australia, Roche Diagnostics Germany, all outside the submitted work. WEH has provided paid consultancies to AO foundation Switzerland and MDI International Australia, all outside the submitted work.WEH has received financial support for a congress he chaired from EBSCO Germany, Isabel Healthcare UK, Mundipharma Medical Switzerland, VisualDx USA, all outside the submitted work.MM has been funded by the Bangerter Foundation and the Swiss Academy of Medical Sciences through the "Young Talents in Clinical Research" (grant TCR 14/17) as well with an in-house grant of the Clinical Trial Unit.TCS holds the endowed professorship of emergency telemedicine at the University of Bern sponsored by the Touring Club Switzerland. The sponsor has no influence on the research or decision to publish.All other authors have nothing to disclose.